A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis

被引:0
作者
E. Stogmann
S. El Tawil
J. Wagenstaller
A. Gaber
S. Edris
A. Abdelhady
E. Assem-Hilger
F. Leutmezer
S. Bonelli
C. Baumgartner
F. Zimprich
T. M. Strom
A. Zimprich
机构
[1] General Hospital,Department of Neurology
[2] Medical University of Vienna,Department of Neurology
[3] Ain Shams University,Institute of Human Genetics
[4] GSF National Research Centre for Environment and Health,Department of Molecular Biology
[5] Ain Shams University,Institute of Human Genetics
[6] Technical University Munich,undefined
来源
neurogenetics | 2009年 / 10卷
关键词
gene; Neuronal ceroid lipofuscinosis; Missense mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Neuronal ceroid lipofuscinoses (NCL) are lysosomal storage disorders and constitute the most common group of progressive neurodegenerative diseases in childhood. Most NCLs are inherited in a recessive manner and are clinically characterised by a variable age at onset, epileptic seizures, psychomotor decline, visual impairment and premature death. To date, eight causative genes have been identified to underlie various clinical forms of NCL. We performed a genome-wide linkage analysis followed by sequencing the recently described NCL gene MFSD8 in three affected and three unaffected members of a consanguineous Egyptian family with an autosomal recessively inherited progressive neurodegenerative disorder. The clinical picture of the patients was compatible with a late infantile NCL (LINCL); however, impairment of the visual system was not a cardinal symptom in the respective family. By linkage analysis, we identified two putative loci on chromosome 1p36.11-p35.1 and 4q28.1-q28.2. The latter locus (4q28.1-q28.2) contained the MFSD8 gene, comprising a novel homozygous missense mutation in exon 5 (c.362a>g /p.Tyr121Cys), which segregated with the disease in the three affected sibs. We describe a novel mutation in the previously identified MFSD8 gene in a family with a common phenotype of LINCL, but no clinical report of vision loss. Our results enlarge the mutational and perhaps the nosological spectrum of one of the recently identified subtypes of NCL, called CLN7.
引用
收藏
页码:73 / 77
页数:4
相关论文
共 65 条
[1]  
Haltia M(2006)The neuronal ceroid-lipofuscinoses: from past to present Biochim Biophys Acta 1762 850-856
[2]  
Haltia M(2003)The neuronal ceroid-lipofuscinoses J Neuropathol Exp Neurol 62 1-13
[3]  
Santavuori P(2000)Neuronal ceroid lipofuscinoses in childhood Suppl Clin Neurophysiol 53 443-451
[4]  
Lauronen L(2004)Current state of clinical and morphological features in human NCL Brain Pathol 14 61-69
[5]  
Kirveskari K(2001)Pheno/genotypic correlations of neuronal ceroid lipofuscinoses Neurology 57 576-581
[6]  
Aberg L(2006)Molecular genetics of the NCLs—status and perspectives Biochim Biophys Acta 1762 857-864
[7]  
Sainio K(2006)Neuronal ceroid lipofuscinoses (NCL) Eur J Paediatr Neurol 10 255-257
[8]  
Goebel HH(2004)The genetic spectrum of human neuronal ceroid-lipofuscinoses Brain Pathol 14 70-76
[9]  
Wisniewski KE(2006)Diagnosis of the neuronal ceroid lipofuscinoses: an update Biochim Biophys Acta 1762 865-872
[10]  
Wisniewski KE(2002)Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations Am J Med Genet 112 347-354